Second COVID-19 mRNA vaccine dose found safe following allergic reactions to first dose
Allergists encourage patients to complete their vaccination series
(Press-News.org) BOSTON - In a multi-hospital analysis of individuals who experienced an allergic reaction to their first mRNA COVID-19 vaccine dose, all patients who went on to receive a second dose tolerated it without complications. The research, which was led by allergists at Massachusetts General Hospital (MGH) and is published in JAMA Internal Medicine, indicates that a first dose reaction to COVID-19 vaccination should not keep people from getting a second dose.
Allergic reactions after mRNA COVID-19 vaccinations have been reported to be as high as 2%, with anaphylaxis--a life-threatening whole-body allergic reaction--occurring in up to 2.5 per 10,000 people. To examine whether it's safe to proceed with a second mRNA COVID-19 vaccine dose after a dose one reaction, investigators from MGH, Vanderbilt University Medical Center, University of Texas Southwestern Medical Center and Yale School of Medicine combined data from patients who sought allergy specialist care at their hospitals after a reaction to their first mRNA COVID-19 vaccine dose. "These reactions could include symptoms such as itching or hives or flushing. The patients included were all advised by allergy specialists after their dose one reaction," explains co-lead author Matthew S. Krantz, MD, of Vanderbilt University Medical Center.
Among 189 patients, 32 (17%) experienced anaphylaxis after their first dose of mRNA COVID-19 vaccine. A total of 159 patients (84%) went on to receive a second dose. All 159 patients, including 19 individuals who had experienced anaphylaxis following the first dose, tolerated the second dose. Thirty-two patients (20%) reported immediate and potentially allergic symptoms associated with the second dose that were self-limited, mild, and/or resolved with antihistamines alone.
"One important point from this study is that these immediate onset mRNA vaccine reactions may not be mechanistically caused by classic allergy, called immediate hypersensitivity or Ig-E-mediated hypersensitivity. For classic allergy, re-exposure to the allergen causes the same or even worse symptoms," says co-senior author Kimberly G. Blumenthal, MD, MSc, co-director of the Clinical Epidemiology Program within MGH's Division of Rheumatology, Allergy and Immunology.
The study's findings suggest that it's safe for most individuals to receive a second dose of the mRNA COVID-19 vaccine, notes co-senior author Aleena Banerji, MD, clinical director of the Allergy and Clinical Immunology Unit at MGH. "After first dose reactions, allergy specialists may be useful to help guide risk/benefit assessments and assist with completion of safe vaccination," she says.
This study was funded by the National Institutes of Health and MGH.
About the Massachusetts General Hospital
Massachusetts General Hospital, founded in 1811, is the original and largest teaching hospital of Harvard Medical School. The Mass General Research Institute conducts the largest hospital-based research program in the nation, with annual research operations of more than $1 billion and comprises more than 9,500 researchers working across more than 30 institutes, centers and departments. In August 2020, Mass General was named #6 in the U.S. News & World Report list of "America's Best Hospitals."
ELSE PRESS RELEASES FROM THIS DATE:
Plants, including crops such as rice and wheat, obtain their essential mineral nutrients and water through their roots, making them an important interface between plants and the soil environment. The roots of land plants associate with a wide range of microbes - including bacteria - that are recruited from the surrounding soil and assemble into structured communities known as the root microbiota. These microbial communities are sustained by the plant host, which provides them with nutrients, primarily in the form of organic carbon compounds secreted by the root. In turn, these commensal bacteria mediate multiple processes ...
New York, NY (July 26, 2021) - Researchers have identified a rare class of genetic differences transmitted from parents without autism to their affected children with autism and determined that they are most prominent in "multiplex" families with more than one family member on the spectrum. These findings are reported in Recent ultra-rare inherited variants implicate new autism candidate risk genes, END ...
Bethesda, MD (July 26, 2021) -- There is an urgent need to develop and implement effective screening, diagnosis and treatment strategies for patients with nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH), common liver conditions with a rising burden in the U.S. and globally. This is particularly important for the most at-risk patients, those with diabetes and obesity.
As a critical first step, the American Gastroenterological Association (AGA) -- in collaboration with seven professional associations -- convened an international conference of 32 experts to develop a multidisciplinary action plan to improve care for the growing population of patients with NAFLD ...
How do you study a group of organisms with over 300,000 species, dispersed across all seven continents, and with up to 50 times as much DNA content as the human genome?
This is the question posed to biologists studying the evolutionary history of flowering plants, called angiosperms, whose rapid diversification was so convoluted a problem that Darwin referred to it as the 'abominable mystery.'
This month, both the American Journal of Botany (AJB) and Applications in Plant Sciences (APPS) are devoting their July issues to what has recently become a turning point in the way scientists study the relationships among flowering plants. Dubbed Angiosperms353, the initiative combines ...
DENVER, JULY 26, 2021 -- Improving air quality may improve cognitive function and reduce dementia risk, according to several studies reported today at the END ...
The Covid-19 pandemic and the politicization of health-prevention measures such as vaccination and mask-wearing have highlighted the need for people to accept and trust science.
But trusting science isn't enough.
A new study finds that people who trust science are more likely to believe and disseminate false claims containing scientific references than people who do not trust science. Reminding people of the value of critical evaluation reduces belief in false claims, but reminding them of the value of trusting science does not.
"We conclude that ...
DALLAS, July 26, 2021 -- People who are just beginning treatment for high blood pressure can benefit equally from two different classes of medicine - angiotensin-converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARBs) - yet ARBs may be less likely to cause medication side effects, according to an analysis of real-world data published today in Hypertension, an American Heart Association journal.
While the class of blood pressure-lowering medicines called angiotensin-converting enzyme (ACE) inhibitors may be prescribed more commonly, angiotensin receptor blockers (ARBs) work just as well and may cause fewer side effects. Currently, ACE inhibitors are prescribed more commonly than ARBs as a first-time blood pressure ...
DALLAS, July 26, 2021 -- Genomic studies have produced advances in how to calculate and reduce heart-disease risk, however, the benefits don't necessarily apply to people from historically marginalized racial and ethnic groups and Indigenous populations. Efforts must be made to eliminate barriers to increase their participation in genomic research, according to a new scientific statement from the American Heart Association, published today in the Association's journal Circulation: Genomic and Precision Medicine.
"Profound breakthroughs in genetic and genomic science are rapidly improving our ability to prevent, detect and treat cardiovascular ...
NEW YORK, NY (July 26, 2021)--Two types of drugs that are recommended as a first treatment for patients with high blood pressure were found equally effective in improving cardiovascular outcomes, but the more popular type causes slightly more side effects, finds a multinational observational study led by researchers at Columbia University Vagelos College of Physicians and Surgeons.
The study, which analyzed claims and electronic health data from millions of patients worldwide, is the largest to compare the safety and efficacy of angiotensin-converting ...
Citrus fruits from the mandarin family have important commercial value but how their diversity arose has been something of a mystery
Researchers analyzed the genomes of the East Asian varieties and found a second center of diversity in the Ryukyu Islands along with the previously known center in the mountains of southern China
They discovered a new citrus species native to Okinawa that arose about two million years ago when the Ryukyu archipelago became disconnected from mainland Asia
Other citrus from Okinawa and mainland Japan, including shiikuwasha and tachibana, are hybrids of this newly discovered wild species with different mainland Asian varieties
This research may have commercial implications and ...
LAST 30 PRESS RELEASES:
[Press-News.org] Second COVID-19 mRNA vaccine dose found safe following allergic reactions to first dose
Allergists encourage patients to complete their vaccination series